Denosumab

Open November ’12

Title: A randomised double-blind study of Denosumab V’s Zoledronic Acid (Zometa) in the treatment of bone disease in patients with Newly Diagnosed Multiple Myeloma.

Population: Patients with newly diagnosed MM who are for first line treatment and who have never received previous Intravenous biphosphonate treatment.

Resource Links

http://clinicaltrials.gov/ct2/show/NCT01345019

http://www.myeloma.org.uk/patient-services/faqs/new-myeloma-drugs-and-clinical-studies/

« Back